Deucravacitinib outperformed placebo for treating moderate to severe scalp psoriasis, even among patients with less extensive ...

Between 2000 and 2022, NSAID prescription rates decreased among patients with IBD; opioid prescribing was more common.

The use of SGLT2 inhibitors vs GLP-1 receptor agonists was linked to a reduced risk for ULT and colchicine initiation among ...

Treatment with metformin was associated with improved salivary gland function and reduced ocular symptoms among patients with ...

Throughout 2024, the FDA issued new drug approvals and expanded treatment indications across various rheumatologic diseases.

Frailty is shown to be associated with lower bone mineral density (BMD) in the total hip among a predominantly male cohort of ...

Older patients with a higher comorbidity burden who have nongonococcal bacterial knee septic arthritis are at greater risk ...

Upadacitinib 15 mg plus a 26-week GC taper outperformed placebo in combination with a 52-week GC taper for the treatment of ...

Long-term treatment with anifrolumab significantly reduced the rate of organ damage compared with SOC among patients with SLE ...

Over a 15-year period, prescriptions for analgesics and sedatives to manage HICP decreased while prescriptions for gabapentinoids increased.

The increased risks for arterial thrombotic events (ATE), venous thromboembolism (VTE), and all-cause mortality known to be found among patients with systemic lupus erythematosus (SLE) were validated ...

Utilizing the Dural Substitute Confetti technique during spinal cord stimulation trial implantation may reduce complications and shorten surgery time.